CLASS II ONGOING Device recall · Reported 21 May 2025 · FDA Enforcement Report

Alinity m Resp-4-Plex AMP Kit, List Number 09N79 recalled

Abbott Molecular is recalling Alinity m Resp-4-Plex AMP Kit, List Number 09N79-096, a multiplex real-time reverse, distributed nationwide in the US. The recall was initiated on 28 Apr 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI-DI: 00884929049390; Lot Number: 409384
Quantity recalled656 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1749-2025
FDA event ID
96790
Recalling firm
Abbott Molecular, Des Plaines, IL
Classification
Class II
Status
Ongoing
Recall initiated
28 Apr 2025
FDA classified
12 May 2025
Reported
21 May 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

28 Apr 2025Recall initiated by company
12 May 2025Classified by FDA+14 days
21 May 2025Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

There were reports of an increase in reactive negative controls and false positive results.

Product as listed by the FDA

Alinity m Resp-4-Plex AMP Kit, List Number 09N79-096, a multiplex real-time reverse transcription (RT) polymerase chain reaction (PCR) test intended for the simultaneous qualitative detection and differentiation of RNA from SARS-CoV-2, influenza A virus (flu A), influenza B virus (flu B), and/or Respiratory Syncytial Virus (RSV) in anterior nasal or nasopharyngeal swab specimens collected by a healthcare provider (HCP), or in anterior nasal swab specimens that are self-collected at a healthcare location, from individuals suspected by their HCP of respiratory viral infection consistent with COVID-19.

Where it was distributed

Worldwide - US Nationwide distribution.

Nationwide

Questions about this recall

Why was it recalled?

There were reports of an increase in reactive negative controls and false positive results.

Which lots are affected?

UDI-DI: 00884929049390; Lot Number: 409384

Where was it sold?

Worldwide - US Nationwide distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 96790
ReportedClassRecallCompanyReasonWhere
CLASS IIAlinity m Resp-4-Plex Amplification (AMP) Kit (CE) recalledAbbott MolecularOtherNationwide

More recalls from Abbott Molecular

All 36

Other CPAP & Ventilators recalls

All 554